The Study
Statins, Risk of Dementia and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study (GEMS)
This study found that people who took statins were less likely to get dementia, but it didn't randomly assign people to take them — so maybe those people were just healthier overall. That means we can't say statins definitely caused the lower risk, only that they were linked to it.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
This study looked at whether taking cholesterol-lowering drugs called statins helps healthy older people keep their memory and avoid dementia.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 567 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1The effect is real but small — it means statins might delay dementia by a few months to a year in healthy older adults, but won’t stop it entirely.
- 2In healthy people over 75, statin users had a 43% lower risk of getting Alzheimer’s and a 21% lower risk of any dementia over 6 years.
- 3Lipophilic statins (like atorvastatin) seemed to work better.
- 4But statins didn’t help people who already had mild memory problems.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of Stroke and Cerebrovascular Diseases
Year
2011
Authors
K. Bettermann, A. Arnold, J. Williamson, S. Rapp, K. Sink, J. Toole, M. Carlson, S. Yasar, S. DeKosky, G. Burke
Related Content
Claims (5)
In older adults without cognitive impairment, taking statins is linked to a lower incidence of dementia, regardless of prior cardiovascular disease.
Among adults aged 75 and older without cognitive impairment, those currently taking statins have a 21% lower rate of all-cause dementia and a 43% lower rate of Alzheimer's dementia over six years of follow-up.
Among older adults without cognitive impairment, starting statin medication is linked to a 54% lower incidence of Alzheimer's dementia compared to those who do not take statins, with a suggestion that lipophilic statins like atorvastatin or simvastatin may offer stronger effects.
Among older adults with mild cognitive impairment, taking statins does not lead to a lower risk of developing dementia or a slower rate of cognitive decline over six years.
In older adults without cognitive impairment, taking statins is linked to a slower decline in memory and thinking skills over time, as shown by smaller yearly changes in standardized cognitive test scores.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.